Recent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertension

Electrolyte and Blood Pressure

Volumn 11, Issue 2, 2013, Pages 41-45

  Moon, Ju Young ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

ACE2; Angiotnesin (1 7); Hypertension; Renin angiotensin aldosterone system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; RENIN;

BLOOD LEVEL; BLOOD PRESSURE REGULATION; COMPARATIVE STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART FUNCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MEDICAL DECISION MAKING; NEGATIVE FEEDBACK; NEPHRON; NONHUMAN; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; REVIEW; UPREGULATION;

EID: 84905656547     PISSN: 17385997     EISSN: 20929935     Source Type: Journal    
DOI: 10.5049/EBP.2013.11.2.41     Document Type: Review

References (23)

1. Price DA, Porter LE, Gordon M, et al.: The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 10:2382-2391, 1999 (Pubitemid 29501472)
2. Parving HH, Brenner BM, McMurray JJ, et al.: Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367:2204-2213, 2012
3. Kobori H, Nangaku M, Navar LG, Nishiyama A: The intrarenalrenin- angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59:251-287, 2007 (Pubitemid 47481436)
4. Navar LG, Prieto MC, Satou R, Kobori H: Intrarenalangietensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 11:180-186, 2011
5. Matsusaka T, Niimura F, Shimizu A, et al.: Liver angiotensinogen is the primary source of renal angiotension II. J Am Soc Nephrol 23:1181-1189, 2012
6. Prieto-Carrasquero MC, Kobori H, Ozawa Y, et al.: AT1 receptor-mediated enhancement of collecting duct rennin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol 289:F632-637, 2005 (Pubitemid 41208479)
7. Zhou A, Carrell RW, Murphy MP, et al.: A redox switch in angiotensinogen modulates angiotensin release. Nature 468:108-111, 2010
8. Donoghue M, Hsieh F, Baronas E, et al.: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87:E1-9, 2000.
9. Tipnis SR, Hooper NM, Hyde R, et al.: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238-33243, 2000
10. Vickers C, Hales P, Kaushik V, et al.: Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277:14838-14843, 2002 (Pubitemid 34952556)
11. Crackower MA, Sarao R, Oudit GY, et al.: Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822-828, 2002 (Pubitemid 34670323)
12. Tikellis C, Johnston CI, Forbes JM, et al.: Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41:392-397, 2003 (Pubitemid 36314606)
13. Gallagher PE, Chappell MC, Ferrario CM, Tallant EA: Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol 290:C420-426, 2006
14. Esteban V, Heringer-Walther S, Sterner-Kock A, et al.: Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS One 4:e5406, 2009
15. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC: ACE polymorphisms. Circ Res 98:1123-1133, 2006 (Pubitemid 43948098)
16. Song SB, Jin HS, Hong KW, et al.: Association between renin-angiotensin-aldosterone system-related genes and blood pressure in a Korean population. Blood Press 20:204-210, 2011
17. Burrell LM, Harrap SB, Velkoska E, Patel SK: The ACE2 gene: Its potential as a functional candidate for cardiovascular disease. Clin Sci 124:65-76, 2013
18. Rentzsch B, Todiras M, Iliescu R, et al.: Transgenic angiotensin- converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 52:967-973, 2008
19. Luque M, Martin P, Martell N, et al.: Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens 14:799-805, 1996 (Pubitemid 26187416)
20. Hernández Prada JA, Ferreira AJ, Katovich MJ, et al.: Structure-basedidentification of small-moleculeangiotensin-converting enzyme 2 activators as novel antihyperten-siveagents. Hypertension 51:1312-1317, 2008 (Pubitemid 351555943)
21. Oudit GY, Liu GC, Zhong J, et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59:529-538, 2010
22. Wiemer G, Dobrucki LW, Louka FR, Malinski T, Heitsch H: AVE 0991, a nonpeptide mimic of the effect of angiotensin-(1-7) on the endothelium. Hypertension 40:847-852, 2002 (Pubitemid 35434905)
23. Shemesh R, Toporik A, Levine Z, et al.: Discovery and validation of novel peptideagonists for G-protein-coupled receptors. J Biol Chem 283:34643-34649, 2008